| 证券代码 | CBM.N |
| 证券名称 | 凯姆布雷克斯 |
| 证券类型 | 美股 |
| 上市场所 | 纽约证券交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 1998-03-05 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Cambrex Corporation |
| 注册地址 | 美国特拉华州 |
| 办公地址 | One Meadowlands Plaza, East Rutherford, New Jersey, USA |
| 成立日期 | 1981-12 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.cambrex.com |
| 电话 | +1 (201) 804-3000 |
| 传真 | +1 (201) 804-9852 |
| 公司简介 | Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. |